Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib plus Docetaxel in Advanced Breast Cancer
NCT00494481Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2006
- Primary completion
- Jun 2007
- Countries
- 5
01
Overview
A Phase 2 trial of vandetanib in breast cancer, sponsored by Sanofi. Started Jan 2006; status: completed.
02
Drugs
vandetanib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00494481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00494481.